Want to see JP:4109 full AI Analyst Report?
Stella Chemifa (4109) AI Stock Analysis
Stella Chemifa
(TSE/TYO:4109)
The score is supported primarily by strong financial fundamentals, especially the conservative balance sheet and improving revenue and profitability. Reasonable valuation and dividend income are positives, while the stock’s position below all major moving averages and inconsistent free cash flow weigh on the result.
Stella Chemifa (4109) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 58.72B
- Dividend Yield
- 3.96%
- Average Volume (3M)
- 72.86K
- Price to Earnings (P/E)
- 16.8
- Beta (1Y)
- 0.98
- Revenue Growth
- 3.94%
- EPS Growth
- 14.76%
- Country
- Japan
- Employees
- 683
- Sector
- Basic Materials
- Sector Strength
- 61
- Industry
- Chemicals - Specialty
Stella Chemifa Business Overview & Revenue Model
Company Description
Stella Chemifa Corporation, a Japanese company established in 1916 and headquartered in Osaka, specializes as a global manufacturer and supplier of inorganic fluorine compounds. Formerly known as Hashimoto Chemical Corporation until its rebranding in...
How the Company Makes Money
Stella Chemifa primarily makes money by manufacturing and selling high-purity fluoride chemicals to industrial customers. Its core revenue stream is product sales (rather than subscription or licensing), where customers pay per unit/volume delivered...
Stella Chemifa Financial Statement Overview
Summary
Strong balance sheet with low leverage, rising equity, and positive cash generation support the company. Revenue and profitability are improving, but margin stability and free-cash-flow volatility limit the score.
Income Statement
76PositiveBalance Sheet
88Very PositiveCash Flow
69Positive| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 37.76B | 36.80B | 36.29B | 30.45B | 35.38B | 37.30B |
| Gross Profit | 8.65B | 8.58B | 8.26B | 6.45B | 7.41B | 8.90B |
| EBITDA | 7.63B | 7.53B | 7.15B | 5.49B | 6.11B | 7.29B |
| Net Income | 3.32B | 3.06B | 2.89B | 1.84B | 2.28B | 5.36B |
Balance Sheet | ||||||
| Total Assets | 63.59B | 64.15B | 60.73B | 58.62B | 55.47B | 56.60B |
| Cash, Cash Equivalents and Short-Term Investments | 12.93B | 14.82B | 16.64B | 16.23B | 15.10B | 15.89B |
| Total Debt | 5.27B | 5.75B | 5.56B | 5.12B | 4.14B | 5.59B |
| Total Liabilities | 15.60B | 16.09B | 15.73B | 14.11B | 12.31B | 13.87B |
| Stockholders Equity | 47.74B | 47.83B | 44.75B | 44.26B | 42.92B | 42.22B |
Cash Flow | ||||||
| Free Cash Flow | 0 | 1.43B | 2.95B | 686.00M | 1.05B | 2.70B |
| Operating Cash Flow | 0 | 6.01B | 7.12B | 6.54B | 5.63B | 5.40B |
| Investing Cash Flow | 0 | -8.16B | -4.32B | -5.83B | -3.28B | -2.06B |
| Financing Cash Flow | 0 | 151.00M | -2.83B | -141.00M | -3.72B | -3.52B |
Stella Chemifa Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4109, the sentiment is Negative. The current price of 4680.00 is below the 20-day moving average (MA) of 5043.25, below the 50-day MA of 5190.65, and below the 200-day MA of 5473.24, indicating a bearish trend. The MACD of -159.74 indicates Positive momentum. The RSI at 36.61 is Neutral, neither overbought nor oversold. The STOCH value of 63.09 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:4109.
Stella Chemifa Peers Comparison
Overall Rating
JP:418780Outperform
JP:400875Outperform
JP:411674Outperform
JP:436272Outperform- JP:410970Outperform
JP:407865Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| JP:4187 | 80Outperform | JPY 96.59B | 10.10 | 16.64% | 1.90% | 17.54% | 90.80% |
| JP:4008 | 75Outperform | JPY 93.00B | 9.59 | ― | 4.05% | 4.74% | 124.50% |
| JP:4116 | 74Outperform | JPY 96.04B | 10.66 | ― | 3.86% | 1.64% | -24.06% |
| JP:4362 | 72Outperform | JPY 59.00B | 12.53 | ― | 3.88% | -4.92% | 2.95% |
| JP:4109 | 70Outperform | JPY 58.72B | 16.81 | 7.17% | 3.96% | 3.94% | 14.76% |
| JP:4078 | 65Neutral | JPY 64.26B | 15.50 | ― | 4.58% | -0.23% | -25.47% |
| Sector * | 61Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
* Basic Materials Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:4109 | Stella Chemifa Corporation | 4670.00 | 684.13 | 17.16% | |
| JP:4187 | Osaka Organic Chemical Industry Ltd. | 4360.00 | 572.38 | 15.11% | |
| JP:4008 | Sumitomo Seika Chemicals Co., Ltd. | 1458.00 | 543.72 | 59.47% | |
| JP:4078 | Sakai Chemical Industry Co., Ltd. | 3495.00 | 697.54 | 24.93% | |
| JP:4116 | Dainichiseika Color & Chemicals Mfg.Co., Ltd. | 1328.00 | 396.20 | 42.52% | |
| JP:4362 | Nippon Fine Chemical Co., Ltd. | 2658.00 | 56.70 | 2.18% |
Stella Chemifa Corporate Events
Stella Chemifa Completes ¥1.6 Billion Share Buyback Program
Stella Chemifa Corporation has completed a share buyback program authorized under its articles of incorporation, using provisions of Japan’s Companies Act. The company repurchased 43,100 common shares on the Tokyo Stock Exchange between October...
Stella Chemifa Advances Share Buyback, Repurchases Over 85% of Authorized Shares
Stella Chemifa has disclosed progress on its ongoing share buyback program, acquiring 145,100 common shares for approximately ¥768.9 million through market purchases on the Tokyo Stock Exchange between September 1 and September 30, 2026. This mo...
Stella Chemifa Advances Share Buyback Under Board-Approved Program
Stella Chemifa Corporation has repurchased 111,800 of its own common shares on the Tokyo Stock Exchange between August 7 and August 31, 2026, at a total cost of ¥604,045,500. This buyback is part of a previously approved program authorizing up t...
Stella Chemifa Launches Share Buyback to Boost Capital Efficiency and Shareholder Returns
Stella Chemifa’s board has approved a share repurchase program as part of its fourth medium-term management plan, which targets a return on equity of at least 8% by the fiscal year ending March 2028 and a cumulative total shareholder return rat...
Stella Chemifa Updates Capital- and Stock Price-Conscious Management Policy
Stella Chemifa has updated its framework for management practices that emphasize the cost of capital and stock price, following a fresh review by its Board of Directors. The move reflects an ongoing effort to align corporate strategy with capital eff...
Stella Chemifa posts stronger Q1 profits and keeps upbeat full-year outlook
Stella Chemifa reported solid first-quarter results for the three months to June 30, 2026, with sales revenue rising 10.9% year on year to ¥9.75 billion. Operating profit grew modestly by 1.6% to ¥1.24 billion, while profit attributable to...
FUKADA Corp. Emerges as Stella Chemifa’s Largest Shareholder After Dalton Trims Stake
Stella Chemifa has confirmed a change in its largest major shareholder as of July 10, 2026, following a large shareholding report filed in late July. Property management and real estate leasing firm FUKADA Corporation, together with its joint holders...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 16, 2026